Abiraterone Acetate and Castration Resistant Ductal Adenocarcinoma of the Prostate
Ductal adenocarcinoma of the prostate is a rare histological variant that only represents <1% of prostate tumors. This histological variant has several important clinical implications with respect to their evolution, clinical prognosis, and treatment. We report the case of a 64-year-old patient w...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2014-01-01
|
| Series: | Case Reports in Urology |
| Online Access: | http://dx.doi.org/10.1155/2014/508305 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832548762424180736 |
|---|---|
| author | Edgar Linden-Castro Marcela Pelayo-Nieto Alejandro Alias-Melgar Daniel Espinosa-Perezgrovas Ivan Ramirez-Galindo Gabriel Catalan-Quinto |
| author_facet | Edgar Linden-Castro Marcela Pelayo-Nieto Alejandro Alias-Melgar Daniel Espinosa-Perezgrovas Ivan Ramirez-Galindo Gabriel Catalan-Quinto |
| author_sort | Edgar Linden-Castro |
| collection | DOAJ |
| description | Ductal adenocarcinoma of the prostate is a rare histological variant that only represents <1% of prostate tumors. This histological variant has several important clinical implications with respect to their evolution, clinical prognosis, and treatment. We report the case of a 64-year-old patient with ductal adenocarcinoma of the prostate, which progresses to castration-resistant prostate cancer, that was treated with abiraterone acetate with good clinical response, to our knowledge, the first case of ductal adenocarcinoma of the prostate in treatment with abiraterone acetate. |
| format | Article |
| id | doaj-art-593f6b7919f145e18ad8963e3e9088e3 |
| institution | Kabale University |
| issn | 2090-696X 2090-6978 |
| language | English |
| publishDate | 2014-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Case Reports in Urology |
| spelling | doaj-art-593f6b7919f145e18ad8963e3e9088e32025-02-03T06:13:06ZengWileyCase Reports in Urology2090-696X2090-69782014-01-01201410.1155/2014/508305508305Abiraterone Acetate and Castration Resistant Ductal Adenocarcinoma of the ProstateEdgar Linden-Castro0Marcela Pelayo-Nieto1Alejandro Alias-Melgar2Daniel Espinosa-Perezgrovas3Ivan Ramirez-Galindo4Gabriel Catalan-Quinto5Urology Department, Centro Medico Nacional 20 de Noviembre, Félix Cuevas 540, Del Valle, Benito Juárez, 03229 Ciudad de México, DF, MexicoUrology Department, Centro Medico Nacional 20 de Noviembre, Félix Cuevas 540, Del Valle, Benito Juárez, 03229 Ciudad de México, DF, MexicoUrology Department, Centro Medico Nacional 20 de Noviembre, Félix Cuevas 540, Del Valle, Benito Juárez, 03229 Ciudad de México, DF, MexicoUrology Department, Centro Medico Nacional 20 de Noviembre, Félix Cuevas 540, Del Valle, Benito Juárez, 03229 Ciudad de México, DF, MexicoUrology Department, Centro Medico Nacional 20 de Noviembre, Félix Cuevas 540, Del Valle, Benito Juárez, 03229 Ciudad de México, DF, MexicoUrology Department, Centro Medico Nacional 20 de Noviembre, Félix Cuevas 540, Del Valle, Benito Juárez, 03229 Ciudad de México, DF, MexicoDuctal adenocarcinoma of the prostate is a rare histological variant that only represents <1% of prostate tumors. This histological variant has several important clinical implications with respect to their evolution, clinical prognosis, and treatment. We report the case of a 64-year-old patient with ductal adenocarcinoma of the prostate, which progresses to castration-resistant prostate cancer, that was treated with abiraterone acetate with good clinical response, to our knowledge, the first case of ductal adenocarcinoma of the prostate in treatment with abiraterone acetate.http://dx.doi.org/10.1155/2014/508305 |
| spellingShingle | Edgar Linden-Castro Marcela Pelayo-Nieto Alejandro Alias-Melgar Daniel Espinosa-Perezgrovas Ivan Ramirez-Galindo Gabriel Catalan-Quinto Abiraterone Acetate and Castration Resistant Ductal Adenocarcinoma of the Prostate Case Reports in Urology |
| title | Abiraterone Acetate and Castration Resistant Ductal Adenocarcinoma of the Prostate |
| title_full | Abiraterone Acetate and Castration Resistant Ductal Adenocarcinoma of the Prostate |
| title_fullStr | Abiraterone Acetate and Castration Resistant Ductal Adenocarcinoma of the Prostate |
| title_full_unstemmed | Abiraterone Acetate and Castration Resistant Ductal Adenocarcinoma of the Prostate |
| title_short | Abiraterone Acetate and Castration Resistant Ductal Adenocarcinoma of the Prostate |
| title_sort | abiraterone acetate and castration resistant ductal adenocarcinoma of the prostate |
| url | http://dx.doi.org/10.1155/2014/508305 |
| work_keys_str_mv | AT edgarlindencastro abirateroneacetateandcastrationresistantductaladenocarcinomaoftheprostate AT marcelapelayonieto abirateroneacetateandcastrationresistantductaladenocarcinomaoftheprostate AT alejandroaliasmelgar abirateroneacetateandcastrationresistantductaladenocarcinomaoftheprostate AT danielespinosaperezgrovas abirateroneacetateandcastrationresistantductaladenocarcinomaoftheprostate AT ivanramirezgalindo abirateroneacetateandcastrationresistantductaladenocarcinomaoftheprostate AT gabrielcatalanquinto abirateroneacetateandcastrationresistantductaladenocarcinomaoftheprostate |